News in other languages: 1CM Inc.

04-15	Ucrania aborda el cargamento de cereales rusos "robados" en una conversación telefónica con Israel
21-10-21	Leviathan Natural Products : Israël envisage de construire un nouveau gazoduc vers l'Egypte

More news

Managers and Directors: 1CM Inc.

Manager	Title	Age	Since
Tanvi Bhandari CEO	Chief Executive Officer	-	2022-03-06
Antony Pramoth DFI	Director of Finance/CFO	-	2026-01-06

Director	Title	Age	Since
Tanvi Bhandari BRD	Director/Board Member	-	2022-03-06
Rupalee Mehta BRD	Director/Board Member	-	2022-03-06
Lucas Leone BRD	Director/Board Member	-	2022-03-06

More insiders

1CM Inc. is a Canada-based cannabis company, which is focused on cannabis and other complementary and substitutable retail industries including liquor, tobacco, and nicotine. It's One Cannabis Market is a technology platform that provides business-to-business (B2B) and business-to- consumer (B2C) Solutions, including Last Mile Delivery, Digital Signage, Big Data Analytics & Wholesale Clearing Services. Its Cost Cannabis is a brand for the urban cannabis consumer. Its Costcan Liquor includes a range of spirits, wines, beers, and other alcoholic products, expertly sourced to cater to diverse tastes and preferences. The Company is focused on expanding its operations through organic growth and by way of merger and acquisition transactions.

Employees

Sector

Pharmaceuticals

More about the company

Quotes

Date	Price	Change	Volume
26-06-25	$0.0850	-15.00%	500
26-06-23	$0.1000	+11.11%	32,500
26-06-22	$0.0900	-10.00%	32,839
26-06-19	$0.1000	-25.93%	5,563

Delayed Quote Canadian Securities Exchange

More quotes

Income Statement and Estimates

More financial data

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

Delayed Canadian Securities Exchange Other stock markets 10:23:16 2026-06-25 EDT			5-day change	1st Jan Change
0.0850 ^CAD	-15.00%		-15.00%	-56.41%

04-29	1CM Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 28, 2026	CI
01-30	1CM Inc. Reports Earnings Results for the First Quarter Ended November 30, 2025	CI

Market Cap	11.77M 8.3M 7.29M 6.71M 6.28M 783M 11.99M 80.55M 31.2M 386M 31.15M 30.47M 1.34B	P/E 2024	57.3x	P/E 2025	57.1x
Enterprise Value	9.04M 6.37M 5.6M 5.16M 4.82M 601M 9.21M 61.88M 23.97M 296M 23.93M 23.41M 1.03B	EV / Sales 2024	0.67x	EV / Sales 2025	0.34x
Free-Float	87.25%	Yield 2024 *	-	Yield 2025	-

04-29	1CM Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 28, 2026	CI
01-30	1CM Inc. Reports Earnings Results for the First Quarter Ended November 30, 2025	CI
01-07	1CM Inc. Announces Chief Financial Officer Changes, Effective January 7, 2026	CI
01-07	SNDL Acquires Five Cannabis Outlets From 1CM in Alberta and Saskatchewan	MT
12-29	1CM Inc. Reports Earnings Results for the Full Year Ended August 31, 2025	CI
12-29	1CM Inc. Auditor Raises 'Going Concern' Doubt	CI
25-07-31	1CM Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended May 31, 2025	CI
25-04-29	1CM Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 28, 2025	CI
25-04-09	SNDL Entering Agreement to Buy Cost Cannabis and T Cannabis Locations from 1CM	MT
25-04-08	SNDL Inc. entered into an arrangement agreement to acquire 32 cannabis retail stores from 1CM Inc. for CAD 32.2 million.	CI
25-01-29	1CM Inc. Reports Earnings Results for the First Quarter Ended November 30, 2024	CI
24-12-30	1CM Inc. Reports Earnings Results for the Full Year Ended August 31, 2024	CI
24-12-29	1CM Inc. Auditor Raises 'Going Concern' Doubt	CI

05-27	1CM Provides Update on Arrangement Agreement with SNDL	NE
01-07	1CM Announces CFO Change	NE
12-15	SNDL & 1CM Provide Update Regarding Arrangement	NE
25-06-18	1CM Receives Court Approval for Arrangement with SNDL Inc	NE
25-06-16	1CM Announces Results of Shareholder Meeting	NE

1CM Inc. Stock

Stocks

EPIC

CA68237A1093

Pharmaceuticals

Valuation: 1CM Inc.

Chart: 1CM Inc.

Latest news : 1CM Inc.

Press Releases: 1CM Inc.

News in other languages: 1CM Inc.

Quotes and Performance

Course Extremes

Managers and Directors: 1CM Inc.

Latest insider transactions

Other Pharmaceuticals

Financials

Company Profile

Quotes

Income Statement and Estimates

1 day	-15.00%
1 week	-15.00%
Current month	-55.26%
1 month	-51.43%
3 months	-46.88%
6 months	-48.48%
Current year	-56.41%

1 week	0.08	0.12
1 month	0.08	0.18
Current year	0.08	0.2
1 year	0.08	0.5
3 years	0.08	2.5
5 years	0.08	2.5
10 years	0	2.5

Date	Insider	Type	Main position	Quantity	% Market Cap.
12-17	Harshil Chovatiya	Buy	Chief Financial Officer	37,000	0.0314%
12-10	Harshil Chovatiya	Buy	Chief Financial Officer	1,000	0.0008%
12-10	Harshil Chovatiya	Buy	Chief Financial Officer	44,500	0.0378%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
1CM INC.	-15.00%	-15.00%	-64.58%	-95.00%	8.27M
ELI LILLY AND COMPANY	+1.61%	+3.75%	+43.86%	+151.74%	996B
JOHNSON & JOHNSON	+1.70%	+7.75%	+61.60%	+50.39%	580B
ABBVIE INC.	+3.17%	+12.06%	+30.86%	+79.77%	415B
ROCHE HOLDING AG	+5.66%	-2.44%	+22.01%	+15.66%	326B
NOVARTIS AG	+1.34%	+6.74%	+32.63%	+41.70%	280B
ASTRAZENECA PLC	+1.09%	+6.90%	+37.22%	+24.53%	284B
NOVO NORDISK A/S	+1.32%	+12.69%	-27.48%	-41.27%	210B
AMGEN INC.	+1.47%	+5.41%	+26.93%	+58.35%	190B
GILEAD SCIENCES, INC.	-0.18%	+0.90%	+17.88%	+63.10%	155B
Average	+0.22%	-0.18%	+18.09%	+34.90%	343.67B
Weighted average by Cap.	+2.05%	+2.18%	+35.28%	+72.60%

	2024	2025
Net sales	57.22M 40.32M 35.42M 32.63M 30.51M 3.8B 58.27M 392M 152M 1.88B 151M 148M 6.52B	73.37M 51.7M 45.41M 41.84M 39.12M 4.88B 74.71M 502M 194M 2.4B 194M 190M 8.36B
Net income	616K 434K 381K 351K 328K 40.95M 627K 4.21M 1.63M 20.19M 1.63M 1.59M 70.15M	485K 342K 300K 276K 259K 32.24M 494K 3.32M 1.28M 15.89M 1.28M 1.25M 55.22M
Net Debt	2.88M 2.03M 1.78M 1.64M 1.53M 191M 2.93M 19.69M 7.63M 94.3M 7.61M 7.45M 328M	-2.73M -1.92M -1.69M -1.56M -1.45M -181M -2.78M -18.67M -7.23M -89.44M -7.22M -7.06M -311M